JOIN US
Participants
Participants at the Convergence Forum include an invitation-only group of company founders, senior level executives, investors and healthcare leaders along with a select group of service providers who sponsor the program. Request an invitation or call us at 833-437-1400 if you would like to join us.
Companies JOINing US at the 2026 Convergence Forum include:
Absco Therapeutics
Alexandria Real Estate Equities
Alnylam Pharmaceuticals
Altoida
Aquilo Partners
Arbor Biotechnologies
Arc Fusion
Arcturus Therapeutics
Arrakis Therapeutics
AstraZeneca
Bectas Therapeutics
BIAL Biotech
BiotechTV
Blackbird Laboratories
Bluejay Therapeutics
Breakout Ventures
Chiesi USA
Citizens Private Bank
Corsera Health
DaCapo Brainscience
Delix Therapeutics
Delphia Therapeutics
DLA Piper
Entact Bio
Entrada Therapeutics
Enveda
Evotec
Evvy
Flux Therapeutics
Gallop Oncology
Genepool Networks
General Proximity
Geron
GrayBella Capital
Grove BioPharma
Hevolution
Ipsen
Jefferson River Capital
Johnson & Johnson Innovation -
JJDC
Kynexis Therapeutics
LB Pharmaceuticals
LIBRIS Innovations
Luminary Therapeutics
Lumira Ventures
Lytica Therapeutics
Martrisome Bio
MassBio
Merck
MResult
Novita Pharmaceuticals
Merz Therapeutics
MResult
Neurvati Neurosciences
Neptune Bio
Neurosterix
Normunity
Novo Nordisk
Nucleate
Otsuka Pharmaceutical
Oxford Finance
Pretzel Therapeutics
Q32 Bio
Sante
Satellite Bio
Seismic Therapeutics
Sidley
Spur Therapeutics
SpyBiotech
Syntis Bio
The Timmerman Report
Tiller Therapeutics
Two Bear Capital
USA Today
Versatope Therapeutics
Vertex Ventures HC
WilmerHale